Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Cited by (1,110)

Items 1,101–1,110 of 1,110

1. Therapeutic Modulation of Nitric Oxide Pathways to Address Insulin Resistance in Cardiovascular–Kidney–Metabolic Syndrome
   Ligia-Maria Ceteraș, Vlad Dumitru Brata, Ioana Raluca Dobrotă, Rahela Borbei, Mihai Clim, Teodora Alexescu, Mircea Vasile Milaciu, Mirela-Georgiana Perné, Cezara-Andreea Gerdanovics, Angela Cozma et al. · 2026 · International Journal of Molecular Sciences
2. Immunometabolism in Obesity-Associated Type 2 Diabetes: Molecular Mechanisms and Emerging Therapeutic Targets
   Carlo Acierno, Massimiliano Cavallo, Damiano D’Ardes, Andrea Boccatonda, Davide Nilo, Alfredo Caturano · 2026 · International Journal of Molecular Sciences
3. TRIM28 SUMOylates IRF3 in astrocytes to drive neutrophils infiltration and ischemic cerebral injury
   Hongxin Shu, Qinghua Luo, Ping Hu, Yutian Xu, Wenping Zhu, Li Yang, Kunjian Lei, Ming Luo, Si Zhang, Xinyi Zhu et al. · 2026 · Cell Death and Differentiation
4. Research progress on the pathophysiological mechanisms of pioglitazone-induced heart failure: a review
   Jianli Li, Yifei Zhang, Xuewen Li · 2026 · Frontiers in Cardiovascular Medicine
5. Eighty Years After Vague: Advances in Understanding Ectopic Fat and Metabolic Dysfunction
   Caterina Conte, Priya Sumithran, Carel Wynand le Roux, Alexander Dimitri Miras, Luc Van Gaal · 2026 · Obesity Reviews
6. Expert Consensus on the Clinical Use of the Dapagliflozin–Pioglitazone Fixed-Dose Combination in Adults with Type 2 Diabetes Mellitus in India: PRO-3 Study
   Mathew John, Vijay Panikar, Krishna G. Seshadri, Mithun Bhartia, Dr Ameya Joshi, DAKSHATA A. PADHYE, Nitin Kapoor, Usha Ayyagari, I. Periyandavar, G. Vijayakumar et al. · 2026 · Journal of Diabetology
7. Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
   Melanie Jane Davies, Vanita R. Aroda, Mandeep Singh Bajaj, Nuha A. ElSayed, Francesco Giorgino, Jennifer Green, Rita Rastogi Kalyani, Nisa M. Maruthur, Chantal Mathieu, Sylvia E. Rosas et al. · 2026 · Diabetologia
8. Targeting PPARγ beyond classical agonism: Context-dependent signaling, post-translational regulation, and precision therapeutic opportunities
   Monishankar Kuilya, Sailee Chowdhury, Priyanka Chakraborty, Koyel Kar · 2026 · Next research.
9. Sequencing and combination of therapies in the cardiovascular-kidney-metabolic syndrome: GLP-1 RA, SGLT2 inhibitors, lipid-lowering drugs and mineralocorticoid receptor antagonists
   Michal Dubský · 2026 · Vnitřní lékařství
10. Management of Type 2 Diabetes in Older Adults
    Meenakshi Patel, Radha Reddy, Rajesh Garg · 2026 · Clinics in Geriatric Medicine